Cost of treating diabetic foot ulcers in five different countries

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue SUPPL. 1, 2012, Pages 107-111

  Cavanagh, Peter ^a   Attinger, Christopher ^b   Abbas, Zulfiqarali ^c,d   Bal, Arun ^e   Rojas, Nina ^f   Xu, Zhang Rong ^g  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d Abbas Medical Centre   (Tanzania)

^e All India Institute of Diabetes Mumbai   (India)

^f General Hospital of Concepcion   (Chile)

^g 306 HOSPITAL OF PLA   (China)

Author keywords

Comparative medicine; Cost; Foot ulcer; Health economics; Reimbursement

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ANKLE BRACHIAL INDEX; BELOW KNEE AMPUTATION; CASE REPORT; CAST APPLICATION; CHILE; CHINA; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; DEBRIDEMENT; DIABETIC FOOT; DISEASE DURATION; EXTERNAL FIXATOR; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; HYPERBARIC OXYGEN; INDIA; INFECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SHOE; ORTHOPEDICS; PRIORITY JOURNAL; PROSTHESIS; REHABILITATION CARE; REIMBURSEMENT; REVASCULARIZATION; REVIEW; SHOE; SKIN TRANSPLANTATION; SOFT TISSUE DISEASE; SOFT TISSUE FLAP; TANZANIA; TISSUE FLAP; TREATMENT PLANNING; UNITED STATES; WOUND HEALING; X RAY;

CHILE; CHINA; DIABETIC FOOT; HEALTH CARE COSTS; HUMANS; INDIA; TANZANIA; UNITED STATES;

EID: 84862920433     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2245     Document Type: Review

References (19)

1. Hunt NA, Liu GT, Lavery LA. The economics of limb salvage in diabetes. Plast Reconstr Surg 2011; 127(Suppl 1): 289S-295S.
2. Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale study. Diabetologia 2008; 51: 1826-1834.
3. van Houtum WH, Lavery LA, Harkless LB. The costs of diabetes-related lower extremity amputations in the Netherlands. Diabet Med 1995; 12: 777-781.
4. Ragnarson Tennvall G, Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis 2004; 39(Suppl 2): S132-S139.
5. Horswell RL, Birke JA, Patout CA. A staged management diabetes foot program versus standard care: a 1-year cost and utilization comparison in a state public hospital system. Arch Phys Med Rehabil 2003; 84: 1743-1746.
6. Harrington C, Zagari MJ, Corea J, Klitenic J. A cost analysis of diabetic lower-extremity ulcers. Diabetes Care 2000; 23: 1333-1338.
7. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999; 22: 382-387.
8. Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther 1998; 20: 169-181.
9. Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int 1995; 16: 388-394.
10. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care 2001; 24: 84-88.
11. Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004; 20(Suppl 1): S90-S95.
12. Abbas ZG, Lutale JK, Game FL, Jeffcoate WJ. Comparison of four systems of classification of diabetic foot ulcers in Tanzania. Diabet Med 2008; 25: 134-137.
13. World Bank. 2010. PPP conversion factor. [11 September 2011].
14. International Monetary Fund. 2011. WEO country groups and purchasing power parity (PPP). [10 September 2011].
15. The World Bank. 2011. Data: countries and economies. [9 Setpember 2011].
16. Wolf CF, Gu NY, Doctor JN, Manner PA, Leopold SS. Comparison of one and two-stage revision of total hip arthroplasty complicated by infection: a Markov expected-utility decision analysis. J Bone Joint Surg Am 2011; 93: 631-639.
17. Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg 2010; 52: 17S-22S.
18. Cleemput I, Neyt M, Thiry N, De Laet C, Leys M. Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions. Int J Technol Assess Health Care 2011; 27: 71-76.
19. Organisation for Economic Co-operation and Development. 2011. Health expenditure and financing. [11 September 2011].